Makogon N V, Aleksieieva I M
Fiziol Zh (1994). 2012;58(3):95-112.
PARPs are a large family of 18 enzymes found in most eukaryotes. PARP-1, the most abundant isoform, is activated by DNA breaks and catalyzes the post-translational modification of proteins. It forms polymers ofADP-ribose and attaches them to acceptor proteins, including histones, DNA repair proteins, transcription factors. PARP-1 is a key enzyme involved in a maintenance of genomic stability. Excessive activation of the enzyme has been shown to contribute to tissue injury and inflammatory disorders. PARP is a key mediator of cell death in oxidative stress, ischemia and DNA damage. It also promotes the activation ofproinflammatory gene expression. Inhibition of PARP-1 provides significant protection in animal models of cardiovascular, autoimmune and inflammatory diseases. PARP inhibitors have shown antitumor activity because they compromise ability of cancer cells to repair DNA. PARP-1 is a promising therapeutic target.
聚(ADP-核糖)聚合酶(PARPs)是在大多数真核生物中发现的一个由18种酶组成的大家族。PARP-1是最丰富的同种型,可被DNA断裂激活,并催化蛋白质的翻译后修饰。它形成ADP-核糖聚合物并将其连接到包括组蛋白、DNA修复蛋白、转录因子在内的受体蛋白上。PARP-1是参与维持基因组稳定性的关键酶。该酶的过度激活已被证明会导致组织损伤和炎症性疾病。PARP是氧化应激、缺血和DNA损伤中细胞死亡的关键介质。它还促进促炎基因表达的激活。在心血管、自身免疫和炎症性疾病的动物模型中,抑制PARP-1可提供显著的保护作用。PARP抑制剂已显示出抗肿瘤活性,因为它们损害了癌细胞修复DNA的能力。PARP-1是一个有前景的治疗靶点。